Home
About
AeternaVita Education
Dosages & Research Notes
Educational research summaries for compounds discussed in the peptide community. AeternaVita does not publish human or animal dose protocols, injection schedules, or administration instructions. This page is for laboratory education and risk awareness only.
Adipotide (FTPP)
Also discussed as Fat-Targeted Proapoptotic Peptide and prohibitin-targeting peptide in publicly available educational sources.
What it is
Adipotide is described in public educational sources as an experimental peptide or peptidomimetic studied for targeting white adipose tissue blood-vessel support systems in research models.
Research focus
The research interest is its proposed fat-vasculature targeting mechanism, where disruption of blood supply to adipose tissue is discussed as the central model.
Safety context
Public summaries repeatedly flag kidney or renal toxicity concerns and the absence of an established safe human-use dose.
AeternaVita position
No dosage protocol is provided here. Any page under Education is intended for research context, risk awareness, and responsible non-clinical positioning only.
Important limitation
This page intentionally avoids dosage charts, administration schedules, injection guidance, cycle guidance, or human-use recommendations. If you need calculator support for concentration only, use the Education > Calculator page.
Source notes
- PeptidesCalculator lists Adipotide (FTPP) among peptide calculator/dosage resources and describes calculator fields such as vial size, BAC water, peptide amount, and measured syringe units.
- Peptide Schedule describes Adipotide as research-only and states that no safe human dose has been identified.
- Other public educational summaries describe kidney or renal toxicity concerns and not-approved-for-human-use status.